companies united-therapeutics-corp 
IP Law 360
JUNE 3, 2024
Biopharmaceutical firm United Therapeutics Corp. has accused a former executive of violating an employment agreement by taking ideas to a rival company to develop a competing lung treatment.
IP Law 360
APRIL 29, 2024
and biopharmaceutical firm United Therapeutics Corp. in their estimates of damages suffered by Sandoz when the other company effectively blocked the sale of Sandoz's generic version of a hypertension medication, according to opening statements Monday during a bench trial in New Jersey federal court.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
IP Law 360
MARCH 29, 2024
federal judge Friday denied drugmaker United Therapeutics Corp.'s Food and Drug Administration from approving a new competitor to its blockbuster pulmonary hypertension medication Tyvaso, saying the company was effectively seeking to challenge an agency action before the FDA made one.
LexBlog IP
JUNE 16, 2022
Alvotech, a global biotech company focused solely on the development and manufacture of biosimilar medicines announced yesterday that its ordinary shares and warrants will begin trading on Nasdaq today, June 16, under the new ticker symbols “ALVO” and “ALVOW”, respectively. and Icelandic stock exchange. For the U.S.
The TTABlog
JULY 5, 2022
Coca-Cola Company , 2022 USPQ2d 602 Fed. Coca-Cola has been selling THUMS UP and LIMCA beverages in India for decades, but not in the United States. Meenaxi began distributing its THUMS UP and LIMCA products in the United States in 2008 and registered the marks in 2012. Brooklyn Brewery Corp. Therapeutic Supplies Pty.
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
At the same time, market uptake of biosimilars in the United States continued to increase, suggesting that there is room for expansion of biosimilars in the U.S. For the first time since FDA licensed the first biosimilar, Sandoz’s Zarxio ® (filgrastim-sndz), in 2015, the United States saw a decrease in annual biosimilar approvals in 2020.
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 7, 2022
See United States v. 6 grants “unreviewable authority” within the executive branch to Administrative Patent Judges (APJs) “incompatible with their status as inferior officers” under the Appointments Clause of the United States Constitution. Reynolds Vapor Company v. We exclude animal vaccines and animal therapeutics.
Expert insights. Personalized for you.
52 
Let's personalize your content